We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-4.92%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.95B
AUM Growth
-$1.04B
Cap. Flow
-$663M
Cap. Flow %
-11.14%
Top 10 Hldgs %
61.43%
Holding
140
New
12
Increased
47
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$26.5M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.49M
3
CI icon
Cigna
CI
+$6.85M
4
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$4.9M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$4.58M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$123M
2
HDB icon
HDFC Bank
HDB
+$78.3M
3
V icon
Visa
V
+$71.4M
4
GILD icon
Gilead Sciences
GILD
+$42M
5
DIS icon
Walt Disney
DIS
+$38.2M

Sector Composition

Rank Sector Weight
1 Financials 33.21%
2 Healthcare 25.04%
3 Communication Services 16.03%
4 Consumer Discretionary 12.69%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
76
Humana
HUM
$43.9B
$2.65M 0.04%
14,800
– –
KITE
77
DELISTED
Kite Pharma, Inc.
KITE
$2.62M 0.04%
47,000
+22,000
+88% +$1.38M
CHRS icon
78
Coherus Oncology
CHRS
$217M
$2.48M 0.04%
124,000
+64,000
+107% +$1.95M
BSX icon
79
Boston Scientific
BSX
$68.4B
$2.46M 0.04%
150,000
– –
ENDP
80
DELISTED
Endo International plc
ENDP
$2.42M 0.04%
35,000
– –
VRTX icon
81
Vertex Pharmaceuticals
VRTX
$123B
$2.41M 0.04%
23,100
+450
+2% +$57.8K
ZLTQ
82
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$2.4M 0.04%
+75,000
New +$2.48M
EXAM
83
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$2.19M 0.04%
75,000
-15,000
-17% -$517K
RGLS
84
DELISTED
Regulus Therapeutics
RGLS
$1.96M 0.03%
2,500
+1,333
+114% +$1.37M
SRNE
85
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.87M 0.03%
222,981
+680
+0.3% +$10.8K
CRDF icon
86
Cardiff Oncology
CRDF
$63M
$1.87M 0.03%
4,564
+695
+18% +$364K
MA icon
87
Mastercard
MA
$498B
$1.8M 0.03%
20,000
-4,000
-17% -$376K
DHR icon
88
Danaher
DHR
$138B
$1.75M 0.03%
30,605
– –
EIX icon
89
Edison International
EIX
$30.3B
$1.7M 0.03%
26,900
– –
OXFD
90
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.63M 0.03%
120,460
– –
REGN icon
91
Regeneron Pharmaceuticals
REGN
$72.9B
$1.59M 0.03%
3,420
+70
+2% +$37.6K
RPRX
92
DELISTED
Repros Therapeutics Inc.
RPRX
$1.49M 0.03%
200,000
– –
TD icon
93
Toronto Dominion Bank
TD
$193B
$1.49M 0.03%
28,220
-6,500
-19% -$259K
KERX
94
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.48M 0.02%
421,110
+1,110
+0.3% +$7.43K
ASXC
95
DELISTED
Asensus Surgical, Inc.
ASXC
$1.44M 0.02%
49,013
– –
JPM icon
96
JPMorgan Chase
JPM
$916B
$1.37M 0.02%
22,500
– –
MD icon
97
Pediatrix Medical
MD
$2.2B
$1.3M 0.02%
17,000
-34,962
-67% -$2.82M
RDUS
98
DELISTED
Radius Health, Inc.
RDUS
$1.27M 0.02%
18,330
+330
+2% +$22.9K
MDT icon
99
Medtronic
MDT
$112B
$1.19M 0.02%
17,800
+1,900
+12% +$140K
MDLZ icon
100
Mondelez International
MDLZ
$83.4B
$1.11M 0.02%
26,500
– –
2 3
4
5 6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q3 2015 Portfolio in Review

As of Q3 2015, C WorldWide Group held 140 positions worth $5.95B, down 15% from $6.99B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

C WorldWide Group withdrew a net $663M in Q3 2015, closing 9 positions and reducing 48 holdings. Its most notable exit was Zimmer Biomet, an estimated $8.68M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, C WorldWide Group opened a new position in Ultragenyx Pharmaceutical worth $3.85M.

  • C WorldWide Group's largest Q3 2015 buy was Ultragenyx Pharmaceutical: 40,000 shares worth $3.85M.
  • C WorldWide Group added most to McKesson in Q3 2015, an estimated $26.5M increase.
  • C WorldWide Group's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $123M.
  • C WorldWide Group fully exited Zimmer Biomet in Q3 2015, selling an estimated $8.68M.
  • C WorldWide Group's ten largest holdings make up 61% of its $5.95B portfolio in Q3 2015.
  • C WorldWide Group opened 12 new positions and closed 9 in Q3 2015.
  • C WorldWide Group's portfolio value fell 15% quarter-over-quarter to $5.95B.

Based on C WorldWide Group's 13F filing for Q3 2015, filed 12 Nov 2015.